Navigation Links
WHO Close to Declaring Swine Flu Pandemic
Date:6/3/2009

Reports of infection on the rise in countries such as Australia and Chile; mortality rate remains low

WEDNESDAY, June 3 (HealthDay News) -- With more cases of the H1N1 swine flu surfacing in the Southern Hemisphere and outside North America, the World Health Organization is weighing whether to declare a global pandemic.

While the vast majority of infections and deaths have occurred in Mexico (the source of the outbreak) and the United States, person-to-person transmission in now being reported in countries such as Australia (501 cases) and Chile (313 cases), as well as Great Britain, Spain and Japan, according to published reports.

"We still are waiting for evidence of really widespread community activity in these countries, and so it's fair to say that they are in transition and are not quite there yet, which is why we are not in phase 6 yet," WHO flu chief Dr. Keiji Fukuda said during a Tuesday press conference at the agency's headquarters in Geneva, Switzerland.

Phase 6 is the highest alert on WHO's scale, representing a global epidemic. In terms of the geographic spread of swine flu, the world is "at phase 5 but getting closer to phase 6," Fukuda said, the Associated Press reported.

The WHO is debating whether to add a second measure that indicates how dangerous the H1N1 swine flu virus is -- rather than just how widespread -- after several countries expressed concerns that declaring a global pandemic could cause mass confusion and panic even though it's still not clear how dangerous the virus will be, the news service said.

To date, the virus has caused 19,273 cases of infection in 66 countries, but just 117 deaths -- 97 of them in Mexico, where the outbreak began, the WHO reported Wednesday.

Since the outbreak started in April, health officials in the United States have said that infections have been mild for the most part, and most patients recover fairly quickly. Testi
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Experiments Get Close to Out-of-Body Experience
2. HEI, Inc. Closes on Sale of RFID Division Assets
3. PSI Brings its Pioneering Efforts to a Close
4. Acute lung injury patients one-third less likely to die in closed model ICUs
5. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
6. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
7. Actor Joe Pantoliano Discloses Depression; Talks About His Latest Movie and His Sensitive Side
8. Stryker Discloses Informal Inquiry Made by United States Securities and Exchange Commission
9. MediKeeper Closes Series A Financing Round with PacifiCap as Lead Investor
10. Packard Childrens Hospital Opens New South Bay Specialty Clinic Bringing Specialty Care Close to Home
11. Nexia Closes Acquisition of Green Endeavors; Landis Salons On Track to Generate Revenues of $2.2 Million in 2007
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
WHO Close to Declaring Swine Flu Pandemic
(Date:5/23/2013)... A medical malpractice case which was filed ... by Lori Mandel, an office manager in her 50’s, ... Ms. Mandel sought the medical expertise of an ... that affected the quality of her life and her ... that her doctor rendered conservative treatment for 2 years, ...
(Date:5/23/2013)... International Science Consortium, Ltd., issued the following statement ... 2013: , Reform of chemical safety legislation will ... , Ensuring the safety and appropriate use ... the EPA,s Toxic Substances Control Act is a ... vision for transforming toxicity testing "from a system ...
(Date:5/23/2013)... in imaging of brain activity developed by Jean ... and his colleagues lead to improved treatment of ... electroencephalogram (EEG) and functional magnetic resonance imaging (fMRI) ... generating epileptic seizures, giving neurosurgeons a better understanding ... These results were presented at the 2013 ...
(Date:5/23/2013)... Bronson Gray HealthDay Reporter , , WEDNESDAY, May 22 ... device used to save an infant born with a serious ... marriage of bioengineering and surgery. A report in the ... the situation that sparked the innovation. At first, the ... began to have difficulty breathing and eating when he was ...
(Date:5/23/2013)... According to a new market report "Service Delivery ... Management (SDM); Telecom Application Server; Service Creation Environment; Orchestration ... published by MarketsandMarkets, the SDP Market is expected to ... 9.15% from 2013 to 2018. , Browse:, ... 84 Figures , 189 Pages and an ...
Breaking Medicine News(10 mins):Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 2Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 3Health News:New imaging techniques used to help patients suffering from epilepsy 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 2Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 3
... , ENGLEWOOD, Colo., Aug. 10 Baxa, ... and administration of fluid medications, announces the launch of a ... and medication safety practices. The Culture of Safety Page, ... share experiences, insights and ideas for improving their profession and ...
... Aug. 10 /PRNewswire-Asia/ -- China Medicine Corporation,(OTC Bulletin ... leading,developer and distributor of prescription and over the ... supplements, and,medical devices and medical formulations, today announced ... a.m. Eastern Time on Thursday, August 13, 2009, ...
... , SAN FRANCISCO, Aug. 10 ... Mark Gastineau to senior vice president and chief executive of ... Unit (ISGBU). Gastineau joined Blue Shield in 2006 as ... underwriting and compliance areas in developing strategies to increase membership ...
... ... and school administrators will help U.S. schools meet growing needs of students with autism ... ... Society announced the publication of professional competencies for teaching students with autism spectrum disorders ...
... , , NEW YORK, Aug. 10 ... letter of intent to form ZiRx Therapeutics, Ltd., a joint venture that ... cell proteins with drugs that potentially block or stop the spread of ... to broad spectrum antiviral drugs as well as drugs that are less ...
... YORK, Aug. 10 In an unprecedented meeting at the UN, ... and currently an opposition leader and human rights protagonist for Iran, ... violations of human rights by the regime in Iran. , ... Secretary General for his June 22 statement of urgent concern over ...
Cached Medicine News:Health News:Baxa Corporation Launches 'Culture of Safety' Facebook Page 2Health News:Baxa Corporation Launches 'Culture of Safety' Facebook Page 3Health News:China Medicine Announces Conference Call to Discuss Second Quarter 2009 Results 2Health News:Mark Gastineau Named Senior Vice President of Individual, Small Group, and Government Business Unit at Blue Shield of California 2Health News:New National Professional Competencies for Teachers of Autism Released by Leaders in the Field 2Health News:New National Professional Competencies for Teachers of Autism Released by Leaders in the Field 3Health News:Rx for Africa, Inc. and Zirus, Inc. Create Joint Venture, ZiRx Therapeutics, Ltd. 2Health News:Rx for Africa, Inc. and Zirus, Inc. Create Joint Venture, ZiRx Therapeutics, Ltd. 3Health News:Former UN Human Rights Rapporteur Offers 7 Points of Action on Iran to the UN Secretary General 2
(Date:5/23/2013)... , May 23, 2013  Hologic, Inc. ... ), a leading developer, manufacturer and supplier of ... with an emphasis on serving the healthcare needs ... observational study in a U.S. clinical practice comparing ... (breast tomosynthesis) with conventional 2D mammography alone showed ...
(Date:5/23/2013)... , May 23, 2013  Spring Bank Pharmaceuticals, ... treatment of viral infections, today announced that it has ... 9200, its investigational, once daily, oral therapy for the ... healthy, HCV-infected patients and is designed to assess both ... 9200 is a first-in-class drug for the treatment of ...
(Date:5/23/2013)... 2013   Direct to implant, or "one ... appropriate option for many women with BRCA (BReast ... breast cancer risk, or with breast cancer. Traditionally, ... a second surgery to insert permanent implants, but ... as mastectomy can be a medically and cosmetically ...
Breaking Medicine Technology:First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3
... , , , , , , ... MIVI-TRUST Phase III Program With Microplasmin Recruits a Total of Over,640 ... (Euronext Brussels: THR), a biopharmaceutical company,focused on the discovery and development ... that it has completed,the enrolment of the second Phase III trial ...
... , NORCROSS, Ga., Dec. 15 Immucor, Inc. (Nasdaq: ... to the blood transfusion industry, today announced that it will ... 6, 2010 after the market close. The Company will host ... a.m. (Eastern Time) to discuss the results. , ...
Cached Medicine Technology:ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4
...
...
The AGC Revision Knee, extends the AGC Family to include implants for severe primary knees or revision. Provides rotational freedom of +/- 2 and varus/valgus freedom of +/- 1.5....
The Performance Knee System is a wide and easy to use system that offers enough options to cover any indication for primary and revision knee surgery, and all this with extensive intraoperative flexi...
Medicine Products: